GSK Stockmann advised InTiCa Systems SE (ISIN DE0005874846, WKN 587484), based in Passau, on its segment change from the regulated market (Prime Standard) to Scale (SME growth market) at the Frankfurt Stock Exchange. On 9 October 2026, the Frankfurt Stock Exchange announced the withdrawal of InTiCa Systems SE shares from the regulated market. The last trading day of the shares in the Prime Standard was 13 October 2026. From 14 October 2026, they will be traded in the Scale segment. The tradability of the shares was ensured at all times.
InTiCa Systems SE had announced the planned segment change on 13 August 2026 in an ad hoc announcement. Moving to the Scale segment reduces the regulatory and administrative costs associated with listing on the regulated market, while maintaining the company’s presence on the capital markets and enabling its shares to continue trading on the Frankfurt Stock Exchange.
The legal basis for the change is Section 39 (2), sentence 2, no. 3, lit. a) of the German Stock Exchange Act (BörsG), which permits the withdrawal of shares from the regulated market without an accompanying delisting acquisition offer, provided that the shares continue to be included in a domestic SME growth market. The shares were admitted to the Scale segment in accordance with Sections 16 to 18 of the General Terms and Conditions of Deutsche Börse AG for the Regulated Unofficial Market (Freiverkehr) on the Frankfurt Stock Exchange, in conjunction with Section 48a of the German Stock Exchange Act (BörsG). No resolution by the Annual General Meeting was required for this.
BankM AG, Frankfurt am Main, acted as the Deutsche Börse Capital Markets Partner supporting InTiCa Systems SE and filing applications in connection with the segment change.
GSK Stockmann provided InTiCa Systems SE with comprehensive advice on stock market law and capital markets law in connection with the segment change.
Advisers of InTiCa Systems SE at GSK Stockmann:
Dr Bernd Graßl (lead, Corporate/Stock Markets/Capital Markets).
